BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 25511737)

  • 1. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
    Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
    Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
    Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
    Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
    Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinoma.
    Zhou S; Du R; Wang Z; Shen W; Gao R; Jiang S; Fang Y; Shi Y; Chang A; Liu L; Liu C; Li N; Xiang R
    Cancer Med; 2019 May; 8(5):2325-2337. PubMed ID: 30957973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
    Liu T; Chen J; Xiao S; Lei X
    Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tg737 acts as a key driver of invasion and migration in liver cancer stem cells and correlates with poor prognosis in patients with hepatocellular carcinoma.
    You N; Tan Y; Zhou L; Huang X; Wang W; Wang L; Wu K; Mi N; Li J; Zheng L
    Exp Cell Res; 2017 Sep; 358(2):217-226. PubMed ID: 28663060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR4 Influences Hepatitis B Virus Related Hepatocellular Carcinoma by Regulating the Wnt/β-Catenin Pathway.
    Yin Y; Li F; Li S; Cai J; Shi J; Jiang Y
    Cell Physiol Biochem; 2017; 42(2):469-479. PubMed ID: 28578348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 4 signaling promotes invasion of hepatocellular carcinoma cells through MKK4/JNK pathway.
    Dong YQ; Lu CW; Zhang L; Yang J; Hameed W; Chen W
    Mol Immunol; 2015 Dec; 68(2 Pt C):671-83. PubMed ID: 26589455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A896G and C1196T Polymorphisms Within the TLR4 Gene Abate Toll-Like Receptor 4-Mediated Signaling in HepG2 Cells.
    Huang C; Zhang H; Bai R; Wang L; Lv J
    DNA Cell Biol; 2017 Nov; 36(11):1029-1038. PubMed ID: 28945461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.
    Chen CL; Tsukamoto H; Liu JC; Kashiwabara C; Feldman D; Sher L; Dooley S; French SW; Mishra L; Petrovic L; Jeong JH; Machida K
    J Clin Invest; 2013 Jul; 123(7):2832-49. PubMed ID: 23921128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine Human Growth Hormone Promotes Invasive and Cancer Stem Cell-Like Behavior of Hepatocellular Carcinoma Cells by STAT3 Dependent Inhibition of CLAUDIN-1 Expression.
    Chen YJ; You ML; Chong QY; Pandey V; Zhuang QS; Liu DX; Ma L; Zhu T; Lobie PE
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28617312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.
    Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX
    Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological characteristics and liver stem cell marker expression in hepatocellular carcinoma involving bile duct tumor thrombi.
    Pang YB; Zhong JH; Luo XL; Ou C; Guo Z; Xiang BD; Peng NF; Li LQ
    Tumour Biol; 2016 May; 37(5):5879-84. PubMed ID: 26586401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
    Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
    Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.
    Dai B; Ruan B; Wu J; Wang J; Shang R; Sun W; Li X; Dou K; Wang D; Li Y
    Int J Clin Exp Pathol; 2014; 7(9):5645-54. PubMed ID: 25337205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma.
    Kawai T; Yasuchika K; Ishii T; Katayama H; Yoshitoshi EY; Ogiso S; Kita S; Yasuda K; Fukumitsu K; Mizumoto M; Hatano E; Uemoto S
    Clin Cancer Res; 2015 Jul; 21(13):3081-91. PubMed ID: 25820415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.